Abbott acquired Cardiovascular Systems, Inc. (CSI), a US-based medical device company that develops and manufactures devices for the treatment of peripheral artery disease (PAD), for USD 850 million. The acquisition was aimed at expanding Abbott's portfolio of PAD products and solutions.
Abbott acquired Global Medical Instrumentation (GMI), a Belgian medical device company that develops and manufactures devices for the treatment of atrial fibrillation (AFib), for USD 4.3 billion. The acquisition was aimed at expanding Abbott's portfolio of AFib products and solutions.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 5314
Published Date: Oct 13, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Increasing demand for healthcare is the major factor driving the market growth.
The market size of coronary sinus reducer is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2024-2036.
The major players in the market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, Cook Medical Incorporated, Terumo Corporation, and others.
The hospital segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.